ALTSHULER DAVID 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 14, 2025
Insider Transaction Report
Form 4
ALTSHULER DAVID
EVP, Chief Scientific Officer
Transactions
- Award
Common Stock
2025-02-12+5,324→ 48,423 total
Footnotes (1)
- [F1]Restricted stock unit award that vests in installments beginning on 02/24/2026.